Presentations & Publications
2020
- Elimination of hepatitis C in Europe: can WHO targets be achieved?
Maticic M, Lombardi A, Mondelli MU, et al. Clin Microbiol Infect 2020 doi: 10.1016/j.cmi.2020.01.014.
2019
- Hepatitis C: Is eradication possible?
Lombardi A, Mondelli MU, Liver Int 2019;39:416-426. doi: 10.1111/liv.14011. - Liver decompensation in HIV/Hepatitis B coinfection in the combination
antiretroviral therapy era does not seem increased compared to hepatitis B
mono-infection.
Lieveld FI, Smit C, Richter C, et al. Liver Int 2019;39:470-483. doi: 10.1111/liv.14000.
2018
- Hepatitis C: Is eradication possible?
Lombardi A, Mondelli MU; ESCMID Study Group for Viral Hepatitis (ESGVH). Liver Int 2018. doi: 10.1111/liv.14011. - Model projections on the impact of HCV treatment in the prevention of HCV
transmission among people who inject drugs in Europe.
Fraser H, Martin NK, Brummer-Korvenkontio H, et al. J Hepatol 2018;68:402-411. doi: 10.1016/j.jhep.2017.10.010 - The success of HCV cure: every rose has thorns.
Salmon-Ceron D, Mondelli MU, Matičič M, Arends JE. J Viral Hepat 2018;25:320-328. doi: 10.1111/jvh.12823
2016
- Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials
and daily practice. Arends JE, Kracht PA, Hoepelman AI; European Study Group for Viral Hepatitis (ESGVH). Clin Microbiol Infect. 2016;22(10):846-852.
CMI Website
eAcademy
EUCAST
